KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $660.9 million.

  • AbCellera Biologics' Non-Current Assets rose 167.81% to $660.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $660.9 million, marking a year-over-year increase of 167.81%. This contributed to the annual value of $609.2 million for FY2024, which is 112.42% down from last year.
  • Latest data reveals that AbCellera Biologics reported Non-Current Assets of $660.9 million as of Q3 2025, which was up 167.81% from $659.9 million recorded in Q2 2025.
  • Over the past 5 years, AbCellera Biologics' Non-Current Assets peaked at $660.9 million during Q3 2025, and registered a low of $220.5 million during Q1 2021.
  • In the last 5 years, AbCellera Biologics' Non-Current Assets had a median value of $579.2 million in 2025 and averaged $525.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 10226.16% in 2021, then plummeted by 1077.07% in 2025.
  • AbCellera Biologics' Non-Current Assets (Quarter) stood at $388.8 million in 2021, then soared by 32.58% to $515.4 million in 2022, then grew by 19.54% to $616.1 million in 2023, then dropped by 1.12% to $609.2 million in 2024, then grew by 8.48% to $660.9 million in 2025.
  • Its Non-Current Assets was $660.9 million in Q3 2025, compared to $659.9 million in Q2 2025 and $579.2 million in Q1 2025.